JP2024536001A5 - - Google Patents
Info
- Publication number
- JP2024536001A5 JP2024536001A5 JP2024513821A JP2024513821A JP2024536001A5 JP 2024536001 A5 JP2024536001 A5 JP 2024536001A5 JP 2024513821 A JP2024513821 A JP 2024513821A JP 2024513821 A JP2024513821 A JP 2024513821A JP 2024536001 A5 JP2024536001 A5 JP 2024536001A5
- Authority
- JP
- Japan
- Prior art keywords
- rcn3
- nucleic acid
- acid molecule
- complement
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163250546P | 2021-09-30 | 2021-09-30 | |
| US63/250,546 | 2021-09-30 | ||
| PCT/US2022/077088 WO2023056254A1 (en) | 2021-09-30 | 2022-09-27 | Reticulocalbin-3 (rcn3) variants and treatment of asthma with interleukin-4 receptor alpha (il4r) antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536001A JP2024536001A (ja) | 2024-10-04 |
| JP2024536001A5 true JP2024536001A5 (https=) | 2025-09-10 |
Family
ID=83902767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513821A Pending JP2024536001A (ja) | 2021-09-30 | 2022-09-27 | レチクロカルビン－３（ｒｃｎ３）バリアント及びインターロイキン－４受容体アルファ（ｉｌ４ｒ）アンタゴニストによる喘息の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230151426A1 (https=) |
| EP (1) | EP4409037A1 (https=) |
| JP (1) | JP2024536001A (https=) |
| KR (1) | KR20240067064A (https=) |
| CN (1) | CN117957332A (https=) |
| CA (1) | CA3230302A1 (https=) |
| IL (1) | IL311480A (https=) |
| MX (1) | MX2024003921A (https=) |
| WO (1) | WO2023056254A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| WO2011156000A2 (en) * | 2010-06-07 | 2011-12-15 | Aerovance, Inc. | Use of il-4/il-13 antagonists to treat eosinophilic disorders |
| AR098155A1 (es) * | 2013-10-23 | 2016-05-04 | Genentech Inc | Métodos para diagnosticar y tratar trastornos eosinofílicos |
-
2022
- 2022-09-27 KR KR1020247007006A patent/KR20240067064A/ko active Pending
- 2022-09-27 US US17/935,785 patent/US20230151426A1/en active Pending
- 2022-09-27 JP JP2024513821A patent/JP2024536001A/ja active Pending
- 2022-09-27 EP EP22793348.8A patent/EP4409037A1/en active Pending
- 2022-09-27 CA CA3230302A patent/CA3230302A1/en active Pending
- 2022-09-27 IL IL311480A patent/IL311480A/en unknown
- 2022-09-27 MX MX2024003921A patent/MX2024003921A/es unknown
- 2022-09-27 CN CN202280059731.6A patent/CN117957332A/zh active Pending
- 2022-09-27 WO PCT/US2022/077088 patent/WO2023056254A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998018967A1 (en) | Polymorphisms in the glucose-6 phosphate dehydrogenase locus | |
| US20150110733A1 (en) | Genetic markers predictive of response to glatiramer acetate | |
| JP2022523301A5 (https=) | ||
| CN103865997B (zh) | 高血压易感基因组的鉴定 | |
| Milojkovic et al. | Frequency of the C1236T, G2677T/A and C3435T MDR1 gene polymorphisms in the Serbian population | |
| US20030129596A1 (en) | Chemical compounds | |
| JP5427352B2 (ja) | ヒト体脂肪量と関連する遺伝子多型に基づく肥満発症リスクの判定方法 | |
| JP2024536001A5 (https=) | ||
| CN106939345B (zh) | 用于检测ii型糖尿病易感基因creb1单核苷酸多态性的pcr-rflp方法及应用 | |
| US20030032099A1 (en) | Methods for predicting susceptibility to obesity and obesity-associated health problems | |
| JP4242590B2 (ja) | 慢性関節リウマチの疾患感受性遺伝子、及びその利用 | |
| JP5904501B2 (ja) | ２型糖尿病の検出方法 | |
| WO2006107031A1 (ja) | 遺伝子一塩基多型解析によるアトピー性皮膚炎の相対罹患危険率の検出方法 | |
| JP2022525456A5 (https=) | ||
| US20030008301A1 (en) | Association between schizophrenia and a two-marker haplotype near PILB gene | |
| CN1814794A (zh) | 瘦素和瘦素受体基因多态性检测芯片及其制备方法和用途 | |
| JP6516128B2 (ja) | 抗甲状腺薬誘発性無顆粒球症リスクを判定するための検査方法及び判定用キット | |
| JP4317376B2 (ja) | 糖尿病性腎症遺伝子の検出方法 | |
| KR102650359B1 (ko) | 약물 과민반응 진단용 snp 및 이를 이용한 진단 방법 | |
| CN113637739B (zh) | 一种SCN5A突变基因、应用以及Brugada综合征检测试剂盒 | |
| JP4859088B2 (ja) | ２型糖尿病に関連するヒトｗｎｔ５ｂ遺伝子多型の検出方法及びキット | |
| US8236497B2 (en) | Methods of diagnosing cardiovascular disease | |
| CN101871003A (zh) | 预测中国人2型糖尿病易感性的试剂盒及引物 | |
| RU2317335C1 (ru) | Способ прогнозирования прогрессирующего течения хронического гепатита с (развития цирроза печени) путем анализа комбинации полиморфизмов генов цитокинов | |
| US20220259656A1 (en) | Blood biomarker and genetic markers associated with response to crth2 receptor antagonists |